Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021

SELL
$15.42 - $21.72 $1.56 Million - $2.19 Million
-100,988 Closed
0 $0
Q2 2021

Jul 23, 2021

BUY
$20.85 - $29.88 $652,438 - $935,004
31,292 Added 44.9%
100,988 $2.11 Million
Q1 2021

Apr 27, 2021

BUY
$24.75 - $39.14 $130,581 - $206,502
5,276 Added 8.19%
69,696 $1.97 Million
Q4 2020

Feb 03, 2021

SELL
$29.0 - $41.62 $871,421 - $1.25 Million
-30,049 Reduced 31.81%
64,420 $2.1 Million
Q3 2020

Oct 27, 2020

SELL
$16.3 - $30.64 $462,251 - $868,919
-28,359 Reduced 23.09%
94,469 $2.9 Million
Q2 2020

Aug 04, 2020

BUY
$7.95 - $18.81 $976,482 - $2.31 Million
122,828 New
122,828 $2 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $598M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.